- Regulatory pathways adapting to innovation
- Strategies of regulatory bodies to enhance support for the development of medicines
- Innovation in clinical trials and drug manufacture
More than 70 participants, including representatives from HPRA Ireland, MHRA UK, BfArM Germany and EMA Europe as well as of academic and business leaders, are committed to strengthen knowledge transfer and facilitate easier and faster development of new medicines. This collaboration will continue in the EU funded PEARRL project over the next three years, helping to pave the future for scientific and commercial drug development in Europe and beyond.
To receive updates and photos from the event follow us on twitter @pearrl_eu. For information on future PEARRL events, please subscribe to firstname.lastname@example.org.